{"id":526085,"date":"2021-08-10T11:03:12","date_gmt":"2021-08-10T15:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/"},"modified":"2021-08-10T11:03:12","modified_gmt":"2021-08-10T15:03:12","slug":"intel-consensys-health-advance-pandemic-research","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/","title":{"rendered":"Intel, ConsenSys Health Advance Pandemic Research"},"content":{"rendered":"

<\/p>\n

Intel, ConsenSys Health Advance Pandemic Research<\/b><\/p>\n

ConsenSys Health applies privacy-preserving blockchain security, with support from Intel\u2019s Pandemic Response Technology Initiative, to help combat COVID-19.<\/b><\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–What\u2019s New: <\/b>Healthcare software solutions provider ConsenSys Health is using blockchain-based data security fueled by Intel technology to conduct research into making clinical trial recruitment more efficient and equitable. On the heels of the World Health Organization\u2019s (WHO) first global report<\/a> on the use of artificial intelligence (AI) for healthcare and medicine, ConsenSys Health is seizing opportunities to apply innovative technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus.\n<\/p>\n

\u201cLong-standing industry challenges have only intensified throughout the COVID-19 pandemic. This is especially true for marginalized communities who consistently battle inequities in access to clinical trials. With the help of Intel\u2019s Pandemic Response Technology Initiative and Intel technology, we are able to better work towards making healthcare more equitable for all.\u201d
\n
<\/i>— Sean Manion, Ph.D., chief scientific officer, ConsenSys Health\n<\/p>\n

How It Works:<\/b> Clinical trial recruitment is expensive, inefficient and time-consuming. As COVID-19 therapeutics move through fast-tracked research pipelines and into clinical trials, it is critical to effectively recruit patients \u2013 including those from more vulnerable populations who consistently battle inequities in access to care \u2013 into those trials while protecting patient privacy.\n<\/p>\n

\nConsenSys Health and a large pharmaceutical company researched a privacy-preserving blockchain-orchestrated federated computing approach to clinical trial matching. Processing electronic health record data was considerably faster with hardware-enhanced security through ConsenSys Health\u2019s Elevated Compute platform optimized for Intel\u00ae Software Guard Extensions (Intel\u00ae SGX) on the latest 3rd Gen Intel\u00ae Xeon\u00ae Scalable platform, compared to previous systems. The benefits of this privacy-preserving approach can be applied across the global pharmaceutical industry to improve patient matching for clinical trials and accelerate treatment discoveries.\n<\/p>\n

Why It Matters:<\/b> The global COVID-19 pandemic brought to light data security challenges and inefficiencies that exist within the healthcare industry. Through grants from Intel\u2019s Pandemic Response Technology Initiative (PRTI)<\/a>, companies like ConsenSys Health can gain accelerated access to Intel security and built-in AI technologies required to fuel new, novel research and scientific discoveries.\n<\/p>\n

\nAs workloads expand from the cloud to the edge, threat models are evolving and it\u2019s more important than ever to secure sensitive data. Rooted in silicon, Intel hardware-based security creates a trusted foundation to help protect data and support multiparty collaboration in highly regulated industries, such as healthcare, while helping maintain data privacy and compliance.\n<\/p>\n

More Context: <\/b>Intel Pandemic Response Technology Initiative (PRTI)<\/a> | Intel Commits $50 Million with Pandemic Response Technology Initiative to Combat Coronavirus<\/a> | Leveraging Technology to Provide Global Pandemic Relief<\/a> | Security News at Intel<\/a><\/p>\n

About Intel <\/b><\/p>\n

\nIntel (Nasdaq: INTC) is an industry leader, creating world-changing technology that enables global progress and enriches lives. Inspired by Moore\u2019s Law, we continuously work to advance the design and manufacturing of semiconductors to help address our customers\u2019 greatest challenges. By embedding intelligence in the cloud, network, edge and every kind of computing device, we unleash the potential of data to transform business and society for the better. To learn more about Intel\u2019s innovations, go to newsroom.intel.com<\/a> and intel.com<\/a>.\n<\/p>\n

\n\u00a9 Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210810005175\/en\/<\/a><\/span><\/p>\n

\nJennifer Foss
\n
425-765-3485
\n
jennifer.foss@intel.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Technology Health Pharmaceutical Other Technology Practice Management Research Software Infectious Diseases Networks Internet Science Data Management Security Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Intel, ConsenSys Health Advance Pandemic Research ConsenSys Health applies privacy-preserving blockchain security, with support from Intel\u2019s Pandemic Response Technology Initiative, to help combat COVID-19. SANTA CLARA, Calif.–(BUSINESS WIRE)–What\u2019s New: Healthcare software solutions provider ConsenSys Health is using blockchain-based data security fueled by Intel technology to conduct research into making clinical trial recruitment more efficient and equitable. On the heels of the World Health Organization\u2019s (WHO) first global report on the use of artificial intelligence (AI) for healthcare and medicine, ConsenSys Health is seizing opportunities to apply innovative technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus. \u201cLong-standing industry challenges have only intensified throughout the COVID-19 pandemic. This is especially true for marginalized communities … <\/p>\n

Continue reading “Intel, ConsenSys Health Advance Pandemic Research”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-526085","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIntel, ConsenSys Health Advance Pandemic Research - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Intel, ConsenSys Health Advance Pandemic Research ConsenSys Health applies privacy-preserving blockchain security, with support from Intel\u2019s Pandemic Response Technology Initiative, to help combat COVID-19. SANTA CLARA, Calif.–(BUSINESS WIRE)–What\u2019s New: Healthcare software solutions provider ConsenSys Health is using blockchain-based data security fueled by Intel technology to conduct research into making clinical trial recruitment more efficient and equitable. On the heels of the World Health Organization\u2019s (WHO) first global report on the use of artificial intelligence (AI) for healthcare and medicine, ConsenSys Health is seizing opportunities to apply innovative technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus. \u201cLong-standing industry challenges have only intensified throughout the COVID-19 pandemic. This is especially true for marginalized communities … Continue reading "Intel, ConsenSys Health Advance Pandemic Research"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-10T15:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Intel, ConsenSys Health Advance Pandemic Research\",\"datePublished\":\"2021-08-10T15:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/\"},\"wordCount\":616,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/\",\"name\":\"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-08-10T15:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intel-consensys-health-advance-pandemic-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intel, ConsenSys Health Advance Pandemic Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/","og_locale":"en_US","og_type":"article","og_title":"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk","og_description":"Intel, ConsenSys Health Advance Pandemic Research ConsenSys Health applies privacy-preserving blockchain security, with support from Intel\u2019s Pandemic Response Technology Initiative, to help combat COVID-19. SANTA CLARA, Calif.–(BUSINESS WIRE)–What\u2019s New: Healthcare software solutions provider ConsenSys Health is using blockchain-based data security fueled by Intel technology to conduct research into making clinical trial recruitment more efficient and equitable. On the heels of the World Health Organization\u2019s (WHO) first global report on the use of artificial intelligence (AI) for healthcare and medicine, ConsenSys Health is seizing opportunities to apply innovative technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus. \u201cLong-standing industry challenges have only intensified throughout the COVID-19 pandemic. This is especially true for marginalized communities … Continue reading \"Intel, ConsenSys Health Advance Pandemic Research\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-10T15:03:12+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Intel, ConsenSys Health Advance Pandemic Research","datePublished":"2021-08-10T15:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/"},"wordCount":616,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/","name":"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-08-10T15:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005175r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Intel, ConsenSys Health Advance Pandemic Research"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=526085"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526085\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=526085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=526085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=526085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}